세계의 인공 장기 시장 규모 : 장기 유형별, 경쟁 구도별, 지역 상황별, 예측

Artificial Organs Market Size And Forecast

Artificial Organs Market size was valued at USD 20.93 Billion in 2024 and is projected to reach USD 35.56 Billion by 2032, growing at a CAGR of 7.56% from 2026 to 2032.

The expansion of the Artificial Organs Market is being driven by rising technological advancements in production methods including bioartificial organ manufacturing, standardization, and automation. The market is comprehensively evaluated in the study on the global Artificial Organs Market. The research provides a thorough analysis of the market's key segments, trends, drivers, restraints, competitive environment, and other important elements.

Global Artificial Organs Market Definition

Artificial organs are medical devices that are implanted or integrated into the body to replicate or enhance the natural functioning of an organ. Artificial organs primarily include implantable devices such as entirely artificial hearts and pacemakers and organ support devices such as dialysis machines and extracorporeal membrane oxygenation (ECMO) devices. Artificial organs are usually formed from individual human stem cells and later cultured in the laboratory. They are mainly composed of plastics in stem cells from transplant recipients who have colonized them. Therefore, the body's immune system does not reject artificial organs.

Global Artificial Organs Market Overview

Growing technological developments in production processes like the creation of bioartificial organs, standardization, and automation are the main reasons fueling the market's expansion. Organ failure is becoming more common among the elderly as a result of significant health issues such as diabetes, heart disease, and chronic renal disease. The need for replacement organs is also growing as injuries from auto accidents and amputations happen more frequently.

Advanced artificial support systems have also been created as a result of improvements in medical technology and increased public awareness of the need to upgrade current medical infrastructure. The development of 3D bioprinting and the production of artificial gadgets by incorporating artificial intelligence (AI) has also improved market prospects. On the other side, the market expansion for artificial organs is constrained by high transplant prices. However, the lack of organ donors and the difficulty in finding them when needed is what is propelling the global development of artificial organ technology.

Global Artificial Organs Market Segmentation Analysis

The Global Artificial Organs Market is segmented based on Organ Type and Geography.

Artificial Organs Market, By Organ Type

• Artificial Heart
• Artificial Kidney
• ArtificialPancreas
• Artificial Lungs
• Artificial Cochlear Implants
• Others

Based on Organ Type, the market is segmented into Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Lungs, Artificial Cochlear Implants, and Others. Due to the rising mortality rate associated with dialysis and the rising demand for artificial kidneys, which is the factor driving the global growth of the Artificial Organs Market, the Artificial Kidney sector commands a sizable market share.

Artificial Organs Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Artificial Organs Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region holds a large number of shares in the market because of the increasing number of chronic diseases, the growing organ transplant acceptance, and the increase in the adoption of advanced technology in the region, which is the factor that boosts the market growth of the Artificial Organs Market.

Key Players

The "Global Artificial Organs Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Boston Scientific Corporation, Berlin Heart GmbH, Baxter International Inc., Edward Lifesciences Corporation, Carmat SA, B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd, Abiomed, Getinge AB, and Medtronic PLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ARTIFICIAL ORGANS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ARTIFICIAL ORGANS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ARTIFICIAL ORGANS MARKET, BY ORGAN TYPE

• 5.1 Overview
• 5.2 Artificial Heart
• 5.3 Artificial Kidney
• 5.4 Artificial Pancreas
• 5.5 Artificial Lungs
• 5.6 Cochlear Implants
• 5.7 Others

6 GLOBAL ARTIFICIAL ORGANS MARKET, BY GEOGRAPHY

• 6.1 Overview
• 6.2 North America
  • 6.2.1 U.S.
  • 6.2.2 Canada
  • 6.2.3 Mexico
• 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 U.K.
  • 6.3.3 France
  • 6.3.4 Rest of Europe
• 6.4 Asia Pacific
  • 6.4.1 China
  • 6.4.2 Japan
  • 6.4.3 India
  • 6.4.4 Rest of Asia Pacific
• 6.5 Rest of the World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 GLOBAL ARTIFICIAL ORGANS MARKET COMPETITIVE LANDSCAPE

• 7.1 Overview
• 7.2 Company Market Ranking
• 7.3 Key Development Strategies

8 COMPANY PROFILES

• 8.1 Boston Scientific Corporation
  • 8.1.1 Overview
  • 8.1.2 Financial Performance
  • 8.1.3 Product Outlook
  • 8.1.4 Key Developments
• 8.2 Berlin Heart GmbH
  • 8.2.1 Overview
  • 8.2.2 Financial Performance
  • 8.2.3 Product Outlook
  • 8.2.4 Key Developments
• 8.3 Baxter International Inc.
  • 8.3.1 Overview
  • 8.3.2 Financial Performance
  • 8.3.3 Product Outlook
  • 8.3.4 Key Developments
• 8.4 Edward Lifesciences Corporation
  • 8.4.1 Overview
  • 8.4.2 Financial Performance
  • 8.4.3 Product Outlook
  • 8.4.4 Key Developments
• 8.5 Carmat SA
  • 8.5.1 Overview
  • 8.5.2 Financial Performance
  • 8.5.3 Product Outlook
  • 8.5.4 Key Developments
• 8.6 B. Braun Melsungen AG
  • 8.6.1 Overview
  • 8.6.2 Financial Performance
  • 8.6.3 Product Outlook
  • 8.6.4 Key Developments
• 8.7 Asahi Kasei Medical Co. Ltd
  • 8.7.1 Overview
  • 8.7.2 Financial Performance
  • 8.7.3 Product Outlook
  • 8.7.4 Key Developments
• 8.8 Abiomed
  • 8.8.1 Overview
  • 8.8.2 Financial Performance
  • 8.8.3 Product Outlook
  • 8.8.4 Key Developments
• 8.9 Getinge AB
  • 8.9.1 Overview
  • 8.9.2 Financial Performance
  • 8.9.3 Product Outlook
  • 8.9.4 Key Developments
• 8.10 Medtronic PLC
  • 8.10.1 Overview
  • 8.10.2 Financial Performance
  • 8.10.3 Product Outlook
  • 8.10.4 Key Developments

9 Appendix

• 9.1 Related Research